dioscin has been researched along with Cardiac Hypertrophy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Lei, L; Li, Q; Li, T | 1 |
1 other study(ies) available for dioscin and Cardiac Hypertrophy
| Article | Year |
|---|---|
Dioscin ameliorates cardiac hypertrophy through inhibition of the MAPK and Akt/GSK3β/mTOR pathways.
Topics: Angiotensin II; Animals; Cardiomegaly; Diosgenin; Glycogen Synthase Kinase 3 beta; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Vasoconstrictor Agents | 2018 |